Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+0.63%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$43B
AUM Growth
+$43B
(-2.8%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
15.68%
Holding
796
New
98
Increased
202
Reduced
384
Closed
81
Top Buys
| 1 |
Nutrien
NTR
|
$193M |
| 2 |
GE Aerospace
GE
|
$174M |
| 3 |
Cigna
CI
|
$119M |
| 4 |
Nektar Therapeutics
NKTR
|
$115M |
| 5 |
Illinois Tool Works
ITW
|
$113M |
Top Sells
| 1 |
RTX Corp
RTX
|
$232M |
| 2 |
CF Industries
CF
|
$199M |
| 3 |
Burlington
BURL
|
$138M |
| 4 |
Puma Biotechnology
PBYI
|
$129M |
| 5 |
Booz Allen Hamilton
BAH
|
$127M |
Sector Composition
| 1 | Technology | 14.59% |
| 2 | Financials | 14.38% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 12.25% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Paychex
PAYX
$50.2B
| $6.02M | 0.01% |
97,746
-3,400
| -3% | -$209K |
|
|
STDY
627
DELISTED
SteadyMed Ltd
STDY
| $6.01M | 0.01% |
1,849,767
| – | – |
|
|
ARNA
628
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.93M | 0.01% |
+150,000
| New | +$5.93M |
|
|
ADXS
629
DELISTED
Advaxis, Inc.
ADXS
| $5.92M | 0.01% |
3,500,000
-500,000
| -13% | -$845K |
|
630
TripAdvisor
TRIP
$2.02B
| $5.88M | 0.01% |
143,800
-9,600
| -6% | -$393K |
|
631
Mattel
MAT
$5.9B
| $5.69M | 0.01% |
432,342
-30,600
| -7% | -$402K |
|
|
DNKN
632
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $5.66M | 0.01% |
+94,784
| New | +$5.66M |
|
633
US Bancorp
USB
$76B
| $5.64M | 0.01% |
111,600
-584,500
| -84% | -$29.5M |
|
634
Aldeyra Therapeutics
ALDX
$351M
| $5.63M | 0.01% |
750,000
+57,000
| +8% | +$428K |
|
635
Henry Schein
HSIC
$8.44B
| $5.61M | 0.01% |
83,400
+24,300
| +41% | +$1.63M |
|
636
Surgery Partners
SGRY
$2.91B
| $5.57M | 0.01% |
+325,000
| New | +$5.57M |
|
637
Garmin
GRMN
$46.5B
| $5.35M | 0.01% |
90,812
-59,800
| -40% | -$3.52M |
|
638
Jabil
JBL
$22B
| $5.17M | 0.01% |
180,000
-66,500
| -27% | -$1.91M |
|
639
Acadia Healthcare
ACHC
$2.12B
| $5.16M | 0.01% |
131,721
-540,000
| -80% | -$21.2M |
|
640
Navient
NAVI
$1.36B
| $5.08M | 0.01% |
387,506
-23,400
| -6% | -$307K |
|
641
Expro
XPRO
$1.44B
| $5.05M | 0.01% |
930,846
| – | – |
|
|
ZSAN
642
DELISTED
Zosano Pharma Corporation
ZSAN
| $5.04M | 0.01% |
+1,000,000
| New | +$5.04M |
|
643
uniQure
QURE
$896M
| $4.66M | 0.01% |
198,482
+100,000
| +102% | +$2.35M |
|
644
ProQR Therapeutics
PRQR
$237M
| $4.61M | 0.01% |
1,500,000
+500,000
| +50% | +$1.54M |
|
|
QTNA
645
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $4.59M | 0.01% |
+335,000
| New | +$4.59M |
|
646
Merit Medical Systems
MMSI
$5.36B
| $4.54M | 0.01% |
100,000
-85,000
| -46% | -$3.85M |
|
647
AAR Corp
AIR
$2.72B
| $4.49M | 0.01% |
+101,786
| New | +$4.49M |
|
|
DISCA
648
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $4.49M | 0.01% |
209,357
-8,142
| -4% | -$175K |
|
|
CALA
649
DELISTED
Calithera Biosciences, Inc
CALA
| $4.41M | 0.01% |
700,000
-800,000
| -53% | -$5.04M |
|
|
CA
650
DELISTED
CA, Inc.
CA
| $4.25M | 0.01% |
125,300
+27,200
| +28% | +$922K |
|